Ritter Pharmaceuticals
Ritter Pharmaceuticals discovers and commercializes treatments for gastrointestinal diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
€13—20m (Dealroom.co estimates Dec 2014.)
Los Angeles California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$1.0m | Seed | ||
N/A | $453k | Debt | |
$2.0m | Seed | ||
N/A | $244k | Grant | |
N/A | $526k | Debt | |
N/A | $3.9m | Seed | |
N/A | $1.6m | Seed | |
$3.7m | Seed | ||
N/A | N/A | IPO | |
$10.0m | Post IPO Equity | ||
Total Funding | €11.8m |